Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: Lack of correlation between in vitro activity and in vivo efficacy

Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington 99164-7040, United States.
Veterinary Immunology and Immunopathology (Impact Factor: 1.75). 02/2008; 121(1-2):8-22. DOI: 10.1016/j.vetimm.2007.07.011
Source: PubMed

ABSTRACT Although CTL are important for control of lentiviruses, including equine infectious anemia virus (EIAV), it is not known if CTL can limit lentiviral replication in the absence of CD4 help and neutralizing antibody. Adoptive transfer of EIAV-specific CTL clones into severe combined immunodeficient (SCID) foals could resolve this issue, but it is not known whether exogenous IL-2 administration is sufficient to support the engraftment and proliferation of CTL clones infused into immunodeficient horses. To address this question we adoptively transferred EIAV Rev-specific CTL clones into four EIAV-challenged SCID foals, concurrent with low-dose aldesleukin (180,000U/m2), a modified recombinant human IL-2 (rhuIL-2) product. The dose was calculated based on the specific activity on equine PBMC in vitro, and resulted in plasma concentrations considered sufficient to saturate high affinity IL-2 receptors in humans. Despite specific activity on equine PBMC that was equivalent to recombinant equine IL-2 and another form of rhuIL-2, aldesleukin did not support the engraftment and expansion of infused CTL clones, and control of viral load and clinical disease did not occur. It was concluded that survival of Rev-specific CTL clones infused into EIAV-challenged SCID foals was not enhanced by aldesleukin at the doses used in this study, and that in vitro specific activity did not correlate with in vivo efficacy. Successful adoptive immunotherapy with CTL clones in immunodeficient horses will likely require higher doses of rhuIL-2, co-infusion of CD4+ T lymphocytes, or administration of equine IL-2.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We develop a mathematical model for the interaction between two competing equine infectious anemia virus strains and neutralizing antibodies. We predict that elimination of one or both virus strains depends on the initial antibody levels, the strength of antibody mediated neutralization, and the persistence of antibody over time. We further show that the ability of a subdominant, neutralization resistant virus to dominate the infection transiently or permanently is dependent on the antibody-mediated neutralization effect. Finally, we determine conditions for persistence of both virus strains. We fit our models to virus titers from horses (foals) with severe combined immunodeficiency to estimate virus-host parameters and to validate analytical results.
    Journal of Theoretical Biology 11/2013; DOI:10.1016/j.jtbi.2013.11.003 · 2.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Choline dihydrogen phosphate (CDHP) is a low melting point organic salt reported to increase the thermal stability of model proteins. The purpose of the current work was to investigate the effect of CDHP on recombinant human interleukin-2 (rhIL-2) functional and structural integrity, a therapeutic protein used for treating advanced melanoma. Structural integrity and biological activity of rhIL-2 formulated in CDHP was measured below and above thermal midpoint unfolding temperature (T m) of the protein. Potential biocompatibility was assessed by exposing splenocytes and the B16F10 cell line to CDHP at various concentrations and conditions of pH. Formulation of rhIL-2 in an aqueous 680 mM CDHP pH 7.4 solution preserved rhIL-2 binding activity when the solution was heated to 23.3 °C above T m. CDHP solutions (≤80 mM), formulated with 0.33% (w/v) NaHCO3 to maintain pH ≥ 7.2, exhibited no cytotoxic activity toward primary splenocytes or B16F10 cells cultures. However, a 10-fold loss in biological activity was observed when rhIL-2 was used in a 30 mM CDHP aqueous solution with NaHCO3 (pH ≥ 7.2) compared to controls without CDHP. Choline DHP increases rhIL-2 thermal stability in the absence of inherent CDHP cytotoxicity. While increased T m is associated with a diminished rhIL-2 biological activity, the protein retains binding ability.
    Cellular and Molecular Bioengineering 12/2012; 5(4). DOI:10.1007/s12195-012-0243-x · 1.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Theileria equi has a biphasic life cycle in horses, with a period of intraleukocyte development followed by patent erythrocytic parasitemia that causes acute and sometimes fatal hemolytic disease. Unlike Theileria spp. that infect cattle (Theileria parva and Theileria annulata), the intraleukocyte stage (schizont) of Theileria equi does not cause uncontrolled host cell proliferation or other significant pathology. Nevertheless, schizont-infected leukocytes are of interest because of their potential to alter host cell function and because immune responses directed against this stage could halt infection and prevent disease. Based on cellular morphology, Theileria equi has been reported to infect lymphocytes in vivo and in vitro, but the specific phenotype of schizont-infected cells has yet to be defined. To resolve this knowledge gap in Theileria equi pathogenesis, peripheral blood mononuclear cells were infected in vitro and the phenotype of infected cells determined using flow cytometry and immunofluorescence microscopy. These experiments demonstrated that the host cell range of Theileria equi was broader than initially reported and included B lymphocytes, T lymphocytes and monocyte/macrophages. To determine if B and T lymphocytes were required to establish infection in vivo, horses affected with severe combined immunodeficiency (SCID), which lack functional B and T lymphocytes, were inoculated with Theileria equi sporozoites. SCID horses developed patent erythrocytic parasitemia, indicating that B and T lymphocytes are not necessary to complete the Theileria equi life cycle in vivo. These findings suggest that the factors mediating Theileria equi leukocyte invasion and intracytoplasmic differentiation are common to several leukocyte subsets and are less restricted than for Theileria annulata and Theileria parva. These data will greatly facilitate future investigation into the relationships between Theileria equi leukocyte tropism and pathogenesis, breed susceptibility, and strain virulence.
    PLoS ONE 10/2013; 8(10):e76996. DOI:10.1371/journal.pone.0076996 · 3.53 Impact Factor


Available from